Multiple myeloma other imaging findings: Difference between revisions
No edit summary |
|||
| Line 12: | Line 12: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 17:12, 26 August 2015
|
Multiple myeloma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Multiple myeloma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Multiple myeloma other imaging findings |
|
Risk calculators and risk factors for Multiple myeloma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Positron emission tomography (PET) scan: When doing this test, a small amount of a radioactive medium is injected into your body and absorbed by the organs or tissues. This radioactive substance gives off energy which in turn is used to produce the images. PET can provide more helpful information than either CT or MRI scans. It is useful to see if the cancer has spread to the lymph nodes and it is also useful for your doctor to locate where the cancer has spread.
PET scan has been shown to be highly sensitive and specific, when combined with MRI it can achieve 100% diagnostic efficacy.[1][2] The use of PET scan has led to earlier diagnosis of multiple myeloma, more accurate therapy assessment, and better prediction of patient outcome. However, these have not been employed as a standard of care by the International Myeloma Working Group.[3]
References
- ↑ Shortt, CP.; Gleeson, TG.; Breen, KA.; McHugh, J.; O'Connell, MJ.; O'Gorman, PJ.; Eustace, SJ. (2009). "Whole-Body MRI versus PET in assessment of multiple myeloma disease activity". AJR Am J Roentgenol. 192 (4): 980–6. doi:10.2214/AJR.08.1633. PMID 19304704. Unknown parameter
|month=ignored (help) - ↑ Agarwal, A.; Chirindel, A.; Shah, BA.; Subramaniam, RM. (2013). "Evolving role of FDG PET/CT in multiple myeloma imaging and management". AJR Am J Roentgenol. 200 (4): 884–90. doi:10.2214/AJR.12.9653. PMID 23521465. Unknown parameter
|month=ignored (help) - ↑ Dimopoulos, M.; Terpos, E.; Comenzo, RL.; Tosi, P.; Beksac, M.; Sezer, O.; Siegel, D.; Lokhorst, H.; Kumar, S. (2009). "International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma". Leukemia. 23 (9): 1545–56. doi:10.1038/leu.2009.89. PMID 19421229. Unknown parameter
|month=ignored (help)